nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—osteoarthritis—Prednisone—multiple sclerosis	0.264	0.5	CpDpCtD
Diflunisal—osteoarthritis—Methylprednisolone—multiple sclerosis	0.264	0.5	CpDpCtD
Diflunisal—ALB—multiple sclerosis	0.196	1	CbGaD
Diflunisal—PTGS2—Triamcinolone—multiple sclerosis	0.0559	0.293	CbGbCtD
Diflunisal—PTGS2—Betamethasone—multiple sclerosis	0.048	0.252	CbGbCtD
Diflunisal—ALB—Prednisone—multiple sclerosis	0.0282	0.148	CbGbCtD
Diflunisal—PTGS2—Dexamethasone—multiple sclerosis	0.0279	0.146	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—multiple sclerosis	0.0166	0.0871	CbGbCtD
Diflunisal—ALB—Methotrexate—multiple sclerosis	0.0141	0.0742	CbGbCtD
Diflunisal—TTR—pineal body—multiple sclerosis	0.0035	0.197	CbGeAlD
Diflunisal—TTR—peripheral nervous system—multiple sclerosis	0.00326	0.183	CbGeAlD
Diflunisal—Niclosamide—STAT3—multiple sclerosis	0.00257	0.627	CrCbGaD
Diflunisal—PTGS2—leg—multiple sclerosis	0.00163	0.0915	CbGeAlD
Diflunisal—Olsalazine—IFNG—multiple sclerosis	0.0013	0.318	CrCbGaD
Diflunisal—TTR—brainstem—multiple sclerosis	0.00109	0.0614	CbGeAlD
Diflunisal—TTR—retina—multiple sclerosis	0.00105	0.0592	CbGeAlD
Diflunisal—TTR—medulla oblongata—multiple sclerosis	0.000762	0.0428	CbGeAlD
Diflunisal—TTR—midbrain—multiple sclerosis	0.000696	0.0391	CbGeAlD
Diflunisal—TTR—spinal cord—multiple sclerosis	0.000679	0.0382	CbGeAlD
Diflunisal—TTR—nervous system—multiple sclerosis	0.000572	0.0322	CbGeAlD
Diflunisal—TTR—central nervous system—multiple sclerosis	0.000551	0.031	CbGeAlD
Diflunisal—TTR—cerebellum—multiple sclerosis	0.000539	0.0303	CbGeAlD
Diflunisal—SLC22A6—brain—multiple sclerosis	0.000448	0.0252	CbGeAlD
Diflunisal—TTR—brain—multiple sclerosis	0.000437	0.0246	CbGeAlD
Diflunisal—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000417	0.159	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000411	0.156	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000411	0.156	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000401	0.153	CbGdCrCtD
Diflunisal—ALB—brain—multiple sclerosis	0.000279	0.0157	CbGeAlD
Diflunisal—PTGS2—medulla oblongata—multiple sclerosis	0.000265	0.0149	CbGeAlD
Diflunisal—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000252	0.0957	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000248	0.0942	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000248	0.0942	CbGdCrCtD
Diflunisal—PTGS1—spinal cord—multiple sclerosis	0.000247	0.0139	CbGeAlD
Diflunisal—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000242	0.0921	CbGdCrCtD
Diflunisal—PTGS2—midbrain—multiple sclerosis	0.000242	0.0136	CbGeAlD
Diflunisal—PTGS2—spinal cord—multiple sclerosis	0.000236	0.0133	CbGeAlD
Diflunisal—PTGS1—nervous system—multiple sclerosis	0.000208	0.0117	CbGeAlD
Diflunisal—PTGS1—central nervous system—multiple sclerosis	0.0002	0.0113	CbGeAlD
Diflunisal—PTGS2—nervous system—multiple sclerosis	0.000199	0.0112	CbGeAlD
Diflunisal—PTGS2—central nervous system—multiple sclerosis	0.000192	0.0108	CbGeAlD
Diflunisal—PTGS2—cerebellum—multiple sclerosis	0.000187	0.0105	CbGeAlD
Diflunisal—Hallucination—Methylprednisolone—multiple sclerosis	0.000172	0.00344	CcSEcCtD
Diflunisal—Chest pain—Mitoxantrone—multiple sclerosis	0.00017	0.0034	CcSEcCtD
Diflunisal—Diarrhoea—Cladribine—multiple sclerosis	0.000169	0.0034	CcSEcCtD
Diflunisal—Visual impairment—Methylprednisolone—multiple sclerosis	0.000166	0.00333	CcSEcCtD
Diflunisal—Feeling abnormal—Azathioprine—multiple sclerosis	0.000166	0.00333	CcSEcCtD
Diflunisal—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000165	0.0033	CcSEcCtD
Diflunisal—Confusional state—Mitoxantrone—multiple sclerosis	0.000164	0.00329	CcSEcCtD
Diflunisal—Dizziness—Cladribine—multiple sclerosis	0.000164	0.00328	CcSEcCtD
Diflunisal—Oedema—Mitoxantrone—multiple sclerosis	0.000163	0.00326	CcSEcCtD
Diflunisal—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000163	0.00326	CcSEcCtD
Diflunisal—Shock—Mitoxantrone—multiple sclerosis	0.00016	0.00321	CcSEcCtD
Diflunisal—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000159	0.0032	CcSEcCtD
Diflunisal—Body temperature increased—Azathioprine—multiple sclerosis	0.000159	0.00319	CcSEcCtD
Diflunisal—PTGS1—brain—multiple sclerosis	0.000159	0.00894	CbGeAlD
Diflunisal—Vomiting—Cladribine—multiple sclerosis	0.000157	0.00316	CcSEcCtD
Diflunisal—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000157	0.00316	CcSEcCtD
Diflunisal—Rash—Cladribine—multiple sclerosis	0.000156	0.00313	CcSEcCtD
Diflunisal—Hallucination—Dexamethasone—multiple sclerosis	0.000156	0.00313	CcSEcCtD
Diflunisal—Hallucination—Betamethasone—multiple sclerosis	0.000156	0.00313	CcSEcCtD
Diflunisal—Dermatitis—Cladribine—multiple sclerosis	0.000156	0.00313	CcSEcCtD
Diflunisal—Anorexia—Mitoxantrone—multiple sclerosis	0.000155	0.00311	CcSEcCtD
Diflunisal—Headache—Cladribine—multiple sclerosis	0.000155	0.00311	CcSEcCtD
Diflunisal—Vision blurred—Prednisolone—multiple sclerosis	0.000154	0.00309	CcSEcCtD
Diflunisal—PTGS2—brain—multiple sclerosis	0.000152	0.00855	CbGeAlD
Diflunisal—Visual impairment—Betamethasone—multiple sclerosis	0.000151	0.00303	CcSEcCtD
Diflunisal—Visual impairment—Dexamethasone—multiple sclerosis	0.000151	0.00303	CcSEcCtD
Diflunisal—Angioedema—Prednisolone—multiple sclerosis	0.000149	0.003	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000149	0.00298	CcSEcCtD
Diflunisal—Hypersensitivity—Azathioprine—multiple sclerosis	0.000148	0.00297	CcSEcCtD
Diflunisal—Nausea—Cladribine—multiple sclerosis	0.000147	0.00295	CcSEcCtD
Diflunisal—Vertigo—Prednisolone—multiple sclerosis	0.000147	0.00295	CcSEcCtD
Diflunisal—Syncope—Prednisolone—multiple sclerosis	0.000147	0.00294	CcSEcCtD
Diflunisal—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000146	0.00293	CcSEcCtD
Diflunisal—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000145	0.00291	CcSEcCtD
Diflunisal—Somnolence—Mitoxantrone—multiple sclerosis	0.000145	0.0029	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisolone—multiple sclerosis	0.000144	0.00288	CcSEcCtD
Diflunisal—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000143	0.00287	CcSEcCtD
Diflunisal—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000141	0.00284	CcSEcCtD
Diflunisal—Fatigue—Mitoxantrone—multiple sclerosis	0.00014	0.00281	CcSEcCtD
Diflunisal—Constipation—Mitoxantrone—multiple sclerosis	0.000139	0.00279	CcSEcCtD
Diflunisal—Diarrhoea—Azathioprine—multiple sclerosis	0.000138	0.00276	CcSEcCtD
Diflunisal—Angioedema—Triamcinolone—multiple sclerosis	0.000137	0.00276	CcSEcCtD
Diflunisal—Angioedema—Methylprednisolone—multiple sclerosis	0.000137	0.00275	CcSEcCtD
Diflunisal—Hallucination—Prednisone—multiple sclerosis	0.000136	0.00273	CcSEcCtD
Diflunisal—Vertigo—Triamcinolone—multiple sclerosis	0.000135	0.00271	CcSEcCtD
Diflunisal—Syncope—Triamcinolone—multiple sclerosis	0.000135	0.00271	CcSEcCtD
Diflunisal—Vertigo—Methylprednisolone—multiple sclerosis	0.000135	0.0027	CcSEcCtD
Diflunisal—Syncope—Methylprednisolone—multiple sclerosis	0.000135	0.0027	CcSEcCtD
Diflunisal—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000134	0.00269	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000134	0.00268	CcSEcCtD
Diflunisal—Oedema—Prednisolone—multiple sclerosis	0.000134	0.00268	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—multiple sclerosis	0.000133	0.00267	CcSEcCtD
Diflunisal—Dizziness—Azathioprine—multiple sclerosis	0.000133	0.00267	CcSEcCtD
Diflunisal—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000133	0.00267	CcSEcCtD
Diflunisal—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000132	0.00265	CcSEcCtD
Diflunisal—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000132	0.00265	CcSEcCtD
Diflunisal—Shock—Prednisolone—multiple sclerosis	0.000131	0.00263	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00013	0.00261	CcSEcCtD
Diflunisal—Urticaria—Mitoxantrone—multiple sclerosis	0.000129	0.00259	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000129	0.00259	CcSEcCtD
Diflunisal—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000129	0.00258	CcSEcCtD
Diflunisal—Vomiting—Azathioprine—multiple sclerosis	0.000128	0.00257	CcSEcCtD
Diflunisal—Rash—Azathioprine—multiple sclerosis	0.000127	0.00255	CcSEcCtD
Diflunisal—Dermatitis—Azathioprine—multiple sclerosis	0.000127	0.00254	CcSEcCtD
Diflunisal—Flushing—Prednisone—multiple sclerosis	0.000127	0.00254	CcSEcCtD
Diflunisal—Headache—Azathioprine—multiple sclerosis	0.000126	0.00253	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000126	0.00253	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—multiple sclerosis	0.000125	0.00251	CcSEcCtD
Diflunisal—Angioedema—Dexamethasone—multiple sclerosis	0.000125	0.0025	CcSEcCtD
Diflunisal—Angioedema—Betamethasone—multiple sclerosis	0.000125	0.0025	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—multiple sclerosis	0.000124	0.00249	CcSEcCtD
Diflunisal—Confusional state—Methylprednisolone—multiple sclerosis	0.000124	0.00248	CcSEcCtD
Diflunisal—Oedema—Triamcinolone—multiple sclerosis	0.000123	0.00246	CcSEcCtD
Diflunisal—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000123	0.00246	CcSEcCtD
Diflunisal—Vertigo—Dexamethasone—multiple sclerosis	0.000123	0.00246	CcSEcCtD
Diflunisal—Vertigo—Betamethasone—multiple sclerosis	0.000123	0.00246	CcSEcCtD
Diflunisal—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000123	0.00246	CcSEcCtD
Diflunisal—Syncope—Dexamethasone—multiple sclerosis	0.000122	0.00246	CcSEcCtD
Diflunisal—Syncope—Betamethasone—multiple sclerosis	0.000122	0.00246	CcSEcCtD
Diflunisal—Sweating—Methotrexate—multiple sclerosis	0.000122	0.00244	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—multiple sclerosis	0.000121	0.00243	CcSEcCtD
Diflunisal—Shock—Triamcinolone—multiple sclerosis	0.000121	0.00242	CcSEcCtD
Diflunisal—Insomnia—Prednisolone—multiple sclerosis	0.000121	0.00242	CcSEcCtD
Diflunisal—Shock—Methylprednisolone—multiple sclerosis	0.000121	0.00242	CcSEcCtD
Diflunisal—Salicylic acid—ALB—multiple sclerosis	0.00012	0.0294	CrCbGaD
Diflunisal—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00012	0.00241	CcSEcCtD
Diflunisal—Loss of consciousness—Betamethasone—multiple sclerosis	0.00012	0.00241	CcSEcCtD
Diflunisal—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00012	0.0024	CcSEcCtD
Diflunisal—Paraesthesia—Prednisolone—multiple sclerosis	0.00012	0.0024	CcSEcCtD
Diflunisal—Nausea—Azathioprine—multiple sclerosis	0.00012	0.0024	CcSEcCtD
Diflunisal—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000119	0.00238	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—multiple sclerosis	0.000119	0.00238	CcSEcCtD
Diflunisal—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000118	0.00238	CcSEcCtD
Diflunisal—Asthenia—Mitoxantrone—multiple sclerosis	0.000117	0.00234	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—multiple sclerosis	0.000114	0.00229	CcSEcCtD
Diflunisal—Vision blurred—Prednisone—multiple sclerosis	0.000112	0.00225	CcSEcCtD
Diflunisal—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000111	0.00223	CcSEcCtD
Diflunisal—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000111	0.00223	CcSEcCtD
Diflunisal—Oedema—Dexamethasone—multiple sclerosis	0.000111	0.00223	CcSEcCtD
Diflunisal—Oedema—Betamethasone—multiple sclerosis	0.000111	0.00223	CcSEcCtD
Diflunisal—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000111	0.00223	CcSEcCtD
Diflunisal—Insomnia—Triamcinolone—multiple sclerosis	0.000111	0.00223	CcSEcCtD
Diflunisal—Insomnia—Methylprednisolone—multiple sclerosis	0.000111	0.00222	CcSEcCtD
Diflunisal—Paraesthesia—Triamcinolone—multiple sclerosis	0.00011	0.00221	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisolone—multiple sclerosis	0.00011	0.00221	CcSEcCtD
Diflunisal—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00011	0.00221	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—multiple sclerosis	0.00011	0.00221	CcSEcCtD
Diflunisal—Shock—Dexamethasone—multiple sclerosis	0.00011	0.0022	CcSEcCtD
Diflunisal—Shock—Betamethasone—multiple sclerosis	0.00011	0.0022	CcSEcCtD
Diflunisal—Dyspnoea—Triamcinolone—multiple sclerosis	0.000109	0.0022	CcSEcCtD
Diflunisal—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000109	0.00219	CcSEcCtD
Diflunisal—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000109	0.00219	CcSEcCtD
Diflunisal—Angioedema—Prednisone—multiple sclerosis	0.000109	0.00218	CcSEcCtD
Diflunisal—Dyspepsia—Triamcinolone—multiple sclerosis	0.000108	0.00217	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—multiple sclerosis	0.000108	0.00216	CcSEcCtD
Diflunisal—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000108	0.00216	CcSEcCtD
Diflunisal—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000108	0.00216	CcSEcCtD
Diflunisal—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000108	0.00216	CcSEcCtD
Diflunisal—Vertigo—Prednisone—multiple sclerosis	0.000107	0.00214	CcSEcCtD
Diflunisal—Syncope—Prednisone—multiple sclerosis	0.000107	0.00214	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—multiple sclerosis	0.000106	0.00213	CcSEcCtD
Diflunisal—Anorexia—Dexamethasone—multiple sclerosis	0.000106	0.00213	CcSEcCtD
Diflunisal—Anorexia—Betamethasone—multiple sclerosis	0.000106	0.00213	CcSEcCtD
Diflunisal—Urticaria—Prednisolone—multiple sclerosis	0.000106	0.00213	CcSEcCtD
Diflunisal—Fatigue—Triamcinolone—multiple sclerosis	0.000106	0.00212	CcSEcCtD
Diflunisal—Fatigue—Methylprednisolone—multiple sclerosis	0.000106	0.00212	CcSEcCtD
Diflunisal—Flurbiprofen—ALB—multiple sclerosis	0.000106	0.0258	CrCbGaD
Diflunisal—Loss of consciousness—Prednisone—multiple sclerosis	0.000104	0.0021	CcSEcCtD
Diflunisal—Vomiting—Mitoxantrone—multiple sclerosis	0.000103	0.00208	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	0.000103	0.00884	CbGpPWpGaD
Diflunisal—Rash—Mitoxantrone—multiple sclerosis	0.000103	0.00206	CcSEcCtD
Diflunisal—Dermatitis—Mitoxantrone—multiple sclerosis	0.000103	0.00206	CcSEcCtD
Diflunisal—Headache—Mitoxantrone—multiple sclerosis	0.000102	0.00204	CcSEcCtD
Diflunisal—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000101	0.00203	CcSEcCtD
Diflunisal—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000101	0.00202	CcSEcCtD
Diflunisal—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000101	0.00866	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000101	0.00866	CbGpPWpGaD
Diflunisal—Insomnia—Dexamethasone—multiple sclerosis	0.000101	0.00202	CcSEcCtD
Diflunisal—Insomnia—Betamethasone—multiple sclerosis	0.000101	0.00202	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.0001	0.00201	CcSEcCtD
Diflunisal—Paraesthesia—Betamethasone—multiple sclerosis	0.0001	0.00201	CcSEcCtD
Diflunisal—Paraesthesia—Dexamethasone—multiple sclerosis	0.0001	0.00201	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisolone—multiple sclerosis	9.84e-05	0.00197	CcSEcCtD
Diflunisal—Dyspepsia—Dexamethasone—multiple sclerosis	9.81e-05	0.00197	CcSEcCtD
Diflunisal—Dyspepsia—Betamethasone—multiple sclerosis	9.81e-05	0.00197	CcSEcCtD
Diflunisal—Urticaria—Triamcinolone—multiple sclerosis	9.75e-05	0.00196	CcSEcCtD
Diflunisal—ALB—Platelet degranulation—PLEK—multiple sclerosis	9.75e-05	0.00836	CbGpPWpGaD
Diflunisal—Urticaria—Methylprednisolone—multiple sclerosis	9.73e-05	0.00195	CcSEcCtD
Diflunisal—Body temperature increased—Triamcinolone—multiple sclerosis	9.71e-05	0.00195	CcSEcCtD
Diflunisal—Oedema—Prednisone—multiple sclerosis	9.7e-05	0.00195	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—multiple sclerosis	9.7e-05	0.00195	CcSEcCtD
Diflunisal—Decreased appetite—Betamethasone—multiple sclerosis	9.68e-05	0.00194	CcSEcCtD
Diflunisal—Decreased appetite—Dexamethasone—multiple sclerosis	9.68e-05	0.00194	CcSEcCtD
Diflunisal—Nausea—Mitoxantrone—multiple sclerosis	9.67e-05	0.00194	CcSEcCtD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	9.64e-05	0.00827	CbGpPWpGaD
Diflunisal—Fatigue—Dexamethasone—multiple sclerosis	9.6e-05	0.00193	CcSEcCtD
Diflunisal—Fatigue—Betamethasone—multiple sclerosis	9.6e-05	0.00193	CcSEcCtD
Diflunisal—Shock—Prednisone—multiple sclerosis	9.55e-05	0.00191	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	9.44e-05	0.0081	CbGpPWpGaD
Diflunisal—Hyperhidrosis—Prednisone—multiple sclerosis	9.38e-05	0.00188	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—multiple sclerosis	9.36e-05	0.00188	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—SRM—multiple sclerosis	9.29e-05	0.00797	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	9.28e-05	0.00797	CbGpPWpGaD
Diflunisal—Anorexia—Prednisone—multiple sclerosis	9.25e-05	0.00185	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	9.21e-05	0.0079	CbGpPWpGaD
Diflunisal—Feeling abnormal—Betamethasone—multiple sclerosis	9.18e-05	0.00184	CcSEcCtD
Diflunisal—Feeling abnormal—Dexamethasone—multiple sclerosis	9.18e-05	0.00184	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.11e-05	0.00183	CcSEcCtD
Diflunisal—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.11e-05	0.00183	CcSEcCtD
Diflunisal—Hypersensitivity—Triamcinolone—multiple sclerosis	9.05e-05	0.00181	CcSEcCtD
Diflunisal—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.03e-05	0.00181	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—multiple sclerosis	8.93e-05	0.00179	CcSEcCtD
Diflunisal—Urticaria—Dexamethasone—multiple sclerosis	8.85e-05	0.00178	CcSEcCtD
Diflunisal—Urticaria—Betamethasone—multiple sclerosis	8.85e-05	0.00178	CcSEcCtD
Diflunisal—Dizziness—Prednisolone—multiple sclerosis	8.83e-05	0.00177	CcSEcCtD
Diflunisal—Asthenia—Triamcinolone—multiple sclerosis	8.81e-05	0.00177	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	8.81e-05	0.00756	CbGpPWpGaD
Diflunisal—Body temperature increased—Dexamethasone—multiple sclerosis	8.81e-05	0.00177	CcSEcCtD
Diflunisal—Body temperature increased—Betamethasone—multiple sclerosis	8.81e-05	0.00177	CcSEcCtD
Diflunisal—Asthenia—Methylprednisolone—multiple sclerosis	8.79e-05	0.00176	CcSEcCtD
Diflunisal—Insomnia—Prednisone—multiple sclerosis	8.77e-05	0.00176	CcSEcCtD
Diflunisal—Paraesthesia—Prednisone—multiple sclerosis	8.71e-05	0.00175	CcSEcCtD
Diflunisal—Pruritus—Triamcinolone—multiple sclerosis	8.69e-05	0.00174	CcSEcCtD
Diflunisal—Pruritus—Methylprednisolone—multiple sclerosis	8.67e-05	0.00174	CcSEcCtD
Diflunisal—UGT1A8—Biological oxidations—POMC—multiple sclerosis	8.61e-05	0.00739	CbGpPWpGaD
Diflunisal—Dyspepsia—Prednisone—multiple sclerosis	8.54e-05	0.00171	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—multiple sclerosis	8.46e-05	0.0017	CcSEcCtD
Diflunisal—Decreased appetite—Prednisone—multiple sclerosis	8.43e-05	0.00169	CcSEcCtD
Diflunisal—Rash—Prednisolone—multiple sclerosis	8.42e-05	0.00169	CcSEcCtD
Diflunisal—Dermatitis—Prednisolone—multiple sclerosis	8.41e-05	0.00169	CcSEcCtD
Diflunisal—Diarrhoea—Methylprednisolone—multiple sclerosis	8.38e-05	0.00168	CcSEcCtD
Diflunisal—Fatigue—Prednisone—multiple sclerosis	8.36e-05	0.00168	CcSEcCtD
Diflunisal—Headache—Prednisolone—multiple sclerosis	8.36e-05	0.00168	CcSEcCtD
Diflunisal—Constipation—Prednisone—multiple sclerosis	8.3e-05	0.00166	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—multiple sclerosis	8.18e-05	0.00164	CcSEcCtD
Diflunisal—Dizziness—Triamcinolone—multiple sclerosis	8.12e-05	0.00163	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—multiple sclerosis	8.11e-05	0.00163	CcSEcCtD
Diflunisal—Dizziness—Methylprednisolone—multiple sclerosis	8.1e-05	0.00162	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—ITGA4—multiple sclerosis	8.03e-05	0.00689	CbGpPWpGaD
Diflunisal—Feeling abnormal—Prednisone—multiple sclerosis	7.99e-05	0.0016	CcSEcCtD
Diflunisal—Asthenia—Betamethasone—multiple sclerosis	7.99e-05	0.0016	CcSEcCtD
Diflunisal—Asthenia—Dexamethasone—multiple sclerosis	7.99e-05	0.0016	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—multiple sclerosis	7.94e-05	0.00159	CcSEcCtD
Diflunisal—Gastrointestinal pain—Prednisone—multiple sclerosis	7.93e-05	0.00159	CcSEcCtD
Diflunisal—Nausea—Prednisolone—multiple sclerosis	7.93e-05	0.00159	CcSEcCtD
Diflunisal—Pruritus—Dexamethasone—multiple sclerosis	7.88e-05	0.00158	CcSEcCtD
Diflunisal—Pruritus—Betamethasone—multiple sclerosis	7.88e-05	0.00158	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—multiple sclerosis	7.84e-05	0.00157	CcSEcCtD
Diflunisal—Vomiting—Triamcinolone—multiple sclerosis	7.81e-05	0.00157	CcSEcCtD
Diflunisal—Vomiting—Methylprednisolone—multiple sclerosis	7.79e-05	0.00156	CcSEcCtD
Diflunisal—Rash—Triamcinolone—multiple sclerosis	7.74e-05	0.00155	CcSEcCtD
Diflunisal—Dermatitis—Triamcinolone—multiple sclerosis	7.73e-05	0.00155	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—multiple sclerosis	7.73e-05	0.00155	CcSEcCtD
Diflunisal—Rash—Methylprednisolone—multiple sclerosis	7.72e-05	0.00155	CcSEcCtD
Diflunisal—Dermatitis—Methylprednisolone—multiple sclerosis	7.72e-05	0.00155	CcSEcCtD
Diflunisal—Urticaria—Prednisone—multiple sclerosis	7.71e-05	0.00155	CcSEcCtD
Diflunisal—Headache—Triamcinolone—multiple sclerosis	7.69e-05	0.00154	CcSEcCtD
Diflunisal—Headache—Methylprednisolone—multiple sclerosis	7.67e-05	0.00154	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—multiple sclerosis	7.67e-05	0.00154	CcSEcCtD
Diflunisal—Diarrhoea—Betamethasone—multiple sclerosis	7.62e-05	0.00153	CcSEcCtD
Diflunisal—Diarrhoea—Dexamethasone—multiple sclerosis	7.62e-05	0.00153	CcSEcCtD
Diflunisal—Dizziness—Dexamethasone—multiple sclerosis	7.37e-05	0.00148	CcSEcCtD
Diflunisal—Dizziness—Betamethasone—multiple sclerosis	7.37e-05	0.00148	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—multiple sclerosis	7.33e-05	0.00147	CcSEcCtD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.3e-05	0.00627	CbGpPWpGaD
Diflunisal—Nausea—Triamcinolone—multiple sclerosis	7.29e-05	0.00146	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—multiple sclerosis	7.28e-05	0.00146	CcSEcCtD
Diflunisal—Nausea—Methylprednisolone—multiple sclerosis	7.28e-05	0.00146	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—multiple sclerosis	7.23e-05	0.00145	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—multiple sclerosis	7.21e-05	0.00145	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisone—multiple sclerosis	7.15e-05	0.00143	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—multiple sclerosis	7.14e-05	0.00143	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	7.12e-05	0.00611	CbGpPWpGaD
Diflunisal—Vomiting—Betamethasone—multiple sclerosis	7.08e-05	0.00142	CcSEcCtD
Diflunisal—Vomiting—Dexamethasone—multiple sclerosis	7.08e-05	0.00142	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—multiple sclerosis	7.05e-05	0.00141	CcSEcCtD
Diflunisal—Rash—Betamethasone—multiple sclerosis	7.02e-05	0.00141	CcSEcCtD
Diflunisal—Rash—Dexamethasone—multiple sclerosis	7.02e-05	0.00141	CcSEcCtD
Diflunisal—Dermatitis—Betamethasone—multiple sclerosis	7.02e-05	0.00141	CcSEcCtD
Diflunisal—Dermatitis—Dexamethasone—multiple sclerosis	7.02e-05	0.00141	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—multiple sclerosis	6.99e-05	0.0014	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—VCAM1—multiple sclerosis	6.99e-05	0.006	CbGpPWpGaD
Diflunisal—Headache—Betamethasone—multiple sclerosis	6.98e-05	0.0014	CcSEcCtD
Diflunisal—Headache—Dexamethasone—multiple sclerosis	6.98e-05	0.0014	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	6.98e-05	0.00599	CbGpPWpGaD
Diflunisal—Asthenia—Prednisone—multiple sclerosis	6.96e-05	0.0014	CcSEcCtD
Diflunisal—Pruritus—Prednisone—multiple sclerosis	6.86e-05	0.00138	CcSEcCtD
Diflunisal—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	6.86e-05	0.00589	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	6.85e-05	0.00588	CbGpPWpGaD
Diflunisal—Feeling abnormal—Methotrexate—multiple sclerosis	6.68e-05	0.00134	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	6.66e-05	0.00572	CbGpPWpGaD
Diflunisal—Diarrhoea—Prednisone—multiple sclerosis	6.64e-05	0.00133	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.63e-05	0.00133	CcSEcCtD
Diflunisal—Nausea—Dexamethasone—multiple sclerosis	6.62e-05	0.00133	CcSEcCtD
Diflunisal—Nausea—Betamethasone—multiple sclerosis	6.62e-05	0.00133	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—CYP24A1—multiple sclerosis	6.54e-05	0.00561	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CYP27B1—multiple sclerosis	6.54e-05	0.00561	CbGpPWpGaD
Diflunisal—Urticaria—Methotrexate—multiple sclerosis	6.44e-05	0.00129	CcSEcCtD
Diflunisal—Dizziness—Prednisone—multiple sclerosis	6.42e-05	0.00129	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—multiple sclerosis	6.41e-05	0.00129	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	6.23e-05	0.00534	CbGpPWpGaD
Diflunisal—Vomiting—Prednisone—multiple sclerosis	6.17e-05	0.00124	CcSEcCtD
Diflunisal—Rash—Prednisone—multiple sclerosis	6.12e-05	0.00123	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—multiple sclerosis	6.11e-05	0.00123	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	6.1e-05	0.00524	CbGpPWpGaD
Diflunisal—Headache—Prednisone—multiple sclerosis	6.08e-05	0.00122	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—GPC5—multiple sclerosis	5.98e-05	0.00514	CbGpPWpGaD
Diflunisal—Hypersensitivity—Methotrexate—multiple sclerosis	5.97e-05	0.0012	CcSEcCtD
Diflunisal—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	5.94e-05	0.00509	CbGpPWpGaD
Diflunisal—Asthenia—Methotrexate—multiple sclerosis	5.82e-05	0.00117	CcSEcCtD
Diflunisal—Nausea—Prednisone—multiple sclerosis	5.76e-05	0.00116	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	5.75e-05	0.00493	CbGpPWpGaD
Diflunisal—Pruritus—Methotrexate—multiple sclerosis	5.74e-05	0.00115	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—SPP1—multiple sclerosis	5.73e-05	0.00491	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	5.65e-05	0.00485	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	5.58e-05	0.00479	CbGpPWpGaD
Diflunisal—Diarrhoea—Methotrexate—multiple sclerosis	5.55e-05	0.00111	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	5.53e-05	0.00475	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	5.48e-05	0.0047	CbGpPWpGaD
Diflunisal—Dizziness—Methotrexate—multiple sclerosis	5.36e-05	0.00108	CcSEcCtD
Diflunisal—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	5.34e-05	0.00459	CbGpPWpGaD
Diflunisal—Vomiting—Methotrexate—multiple sclerosis	5.16e-05	0.00103	CcSEcCtD
Diflunisal—Rash—Methotrexate—multiple sclerosis	5.11e-05	0.00103	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—multiple sclerosis	5.11e-05	0.00102	CcSEcCtD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.1e-05	0.00438	CbGpPWpGaD
Diflunisal—TTR—Disease—GPC5—multiple sclerosis	5.09e-05	0.00437	CbGpPWpGaD
Diflunisal—Headache—Methotrexate—multiple sclerosis	5.08e-05	0.00102	CcSEcCtD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	5.01e-05	0.0043	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—RRM1—multiple sclerosis	4.96e-05	0.00425	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.9e-05	0.0042	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—LINGO1—multiple sclerosis	4.84e-05	0.00415	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	4.84e-05	0.00415	CbGpPWpGaD
Diflunisal—Nausea—Methotrexate—multiple sclerosis	4.82e-05	0.000966	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—ICAM1—multiple sclerosis	4.76e-05	0.00408	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	4.56e-05	0.00391	CbGpPWpGaD
Diflunisal—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	4.56e-05	0.00391	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	4.49e-05	0.00385	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	4.32e-05	0.00371	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL4—multiple sclerosis	4.32e-05	0.0037	CbGpPWpGaD
Diflunisal—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.27e-05	0.00367	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	4.24e-05	0.00364	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	4.21e-05	0.00362	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TAGAP—multiple sclerosis	4.19e-05	0.0036	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	4.03e-05	0.00346	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	4.02e-05	0.00345	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.87e-05	0.00332	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.87e-05	0.00332	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.8e-05	0.00326	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.8e-05	0.00326	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	3.77e-05	0.00324	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.71e-05	0.00318	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—S1PR1—multiple sclerosis	3.67e-05	0.00315	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	3.61e-05	0.0031	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CD58—multiple sclerosis	3.61e-05	0.00309	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MERTK—multiple sclerosis	3.61e-05	0.00309	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SELPLG—multiple sclerosis	3.61e-05	0.00309	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	3.58e-05	0.00307	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GPC5—multiple sclerosis	3.57e-05	0.00306	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	3.54e-05	0.00304	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—ICAM1—multiple sclerosis	3.43e-05	0.00294	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	3.37e-05	0.00289	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	3.35e-05	0.00288	CbGpPWpGaD
Diflunisal—TTR—Disease—RPL5—multiple sclerosis	3.31e-05	0.00284	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.23e-05	0.00277	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	3.21e-05	0.00275	CbGpPWpGaD
Diflunisal—TTR—Disease—SLC11A1—multiple sclerosis	3.17e-05	0.00272	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RGS1—multiple sclerosis	3.12e-05	0.00267	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.08e-05	0.00264	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.08e-05	0.00264	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—CCL2—multiple sclerosis	3.07e-05	0.00263	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.06e-05	0.00262	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—MMP9—multiple sclerosis	3.05e-05	0.00261	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.01e-05	0.00259	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.99e-05	0.00257	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GPR65—multiple sclerosis	2.95e-05	0.00254	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.93e-05	0.00252	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.93e-05	0.00251	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.88e-05	0.00247	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	2.86e-05	0.00245	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—BCHE—multiple sclerosis	2.85e-05	0.00244	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	2.81e-05	0.00241	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.79e-05	0.00239	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	2.78e-05	0.00238	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.72e-05	0.00234	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL13—multiple sclerosis	2.7e-05	0.00232	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCR1—multiple sclerosis	2.7e-05	0.00232	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	2.66e-05	0.00229	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.65e-05	0.00228	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IFNG—multiple sclerosis	2.61e-05	0.00224	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	2.61e-05	0.00224	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.59e-05	0.00222	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	2.57e-05	0.0022	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.56e-05	0.0022	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.55e-05	0.00218	CbGpPWpGaD
Diflunisal—TTR—Disease—CD28—multiple sclerosis	2.53e-05	0.00217	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—TGFB1—multiple sclerosis	2.51e-05	0.00215	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.49e-05	0.00214	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.49e-05	0.00214	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.46e-05	0.00211	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SRM—multiple sclerosis	2.45e-05	0.0021	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.44e-05	0.00209	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	2.38e-05	0.00204	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL1B—multiple sclerosis	2.33e-05	0.002	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL2—multiple sclerosis	2.32e-05	0.00199	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.29e-05	0.00196	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—POMC—multiple sclerosis	2.27e-05	0.00195	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PLEK—multiple sclerosis	2.23e-05	0.00191	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.1e-05	0.0018	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	2.09e-05	0.00179	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	2.08e-05	0.00178	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.07e-05	0.00178	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	2.03e-05	0.00174	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SRM—multiple sclerosis	1.94e-05	0.00167	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.93e-05	0.00166	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCL3—multiple sclerosis	1.93e-05	0.00165	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTGER4—multiple sclerosis	1.85e-05	0.00159	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.85e-05	0.00159	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	1.85e-05	0.00159	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.84e-05	0.00158	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PGR—multiple sclerosis	1.83e-05	0.00157	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	1.81e-05	0.00155	CbGpPWpGaD
Diflunisal—TTR—Disease—CD86—multiple sclerosis	1.81e-05	0.00155	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	1.8e-05	0.00155	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCR3—multiple sclerosis	1.79e-05	0.00154	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CD28—multiple sclerosis	1.77e-05	0.00152	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCR2—multiple sclerosis	1.74e-05	0.00149	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP27B1—multiple sclerosis	1.73e-05	0.00148	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP24A1—multiple sclerosis	1.73e-05	0.00148	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—APOE—multiple sclerosis	1.71e-05	0.00147	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	1.7e-05	0.00146	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—multiple sclerosis	1.69e-05	0.00145	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.69e-05	0.00145	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	1.69e-05	0.00145	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.68e-05	0.00144	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	1.66e-05	0.00142	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CNR1—multiple sclerosis	1.61e-05	0.00138	CbGpPWpGaD
Diflunisal—TTR—Disease—CCR5—multiple sclerosis	1.6e-05	0.00137	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.00135	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SRM—multiple sclerosis	1.57e-05	0.00135	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SELE—multiple sclerosis	1.57e-05	0.00135	CbGpPWpGaD
Diflunisal—TTR—Disease—HLA-A—multiple sclerosis	1.56e-05	0.00134	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB1—multiple sclerosis	1.55e-05	0.00133	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.52e-05	0.00131	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.5e-05	0.00129	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GPC5—multiple sclerosis	1.5e-05	0.00128	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.48e-05	0.00127	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—POMC—multiple sclerosis	1.47e-05	0.00126	CbGpPWpGaD
Diflunisal—TTR—Disease—APOE—multiple sclerosis	1.46e-05	0.00125	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL10—multiple sclerosis	1.45e-05	0.00124	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	1.41e-05	0.00121	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	1.4e-05	0.00121	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	1.38e-05	0.00118	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP27B1—multiple sclerosis	1.37e-05	0.00118	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP24A1—multiple sclerosis	1.37e-05	0.00118	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL6—multiple sclerosis	1.36e-05	0.00117	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.35e-05	0.00116	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ALB—multiple sclerosis	1.34e-05	0.00115	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1.34e-05	0.00115	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.34e-05	0.00115	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	1.34e-05	0.00115	CbGpPWpGaD
Diflunisal—TTR—Disease—CD80—multiple sclerosis	1.32e-05	0.00113	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	1.31e-05	0.00113	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.00112	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CD86—multiple sclerosis	1.27e-05	0.00109	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPC5—multiple sclerosis	1.25e-05	0.00108	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCL5—multiple sclerosis	1.25e-05	0.00107	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SPP1—multiple sclerosis	1.15e-05	0.00099	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ITGA4—multiple sclerosis	1.13e-05	0.000974	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IFNB1—multiple sclerosis	1.13e-05	0.000967	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCR5—multiple sclerosis	1.12e-05	0.000963	CbGpPWpGaD
Diflunisal—TTR—Disease—TYK2—multiple sclerosis	1.11e-05	0.000955	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP24A1—multiple sclerosis	1.11e-05	0.000951	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP27B1—multiple sclerosis	1.11e-05	0.000951	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2RA—multiple sclerosis	1.11e-05	0.000949	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.08e-05	0.000929	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.08e-05	0.000929	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	1.06e-05	0.000908	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—RRM1—multiple sclerosis	1.04e-05	0.000891	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—APOE—multiple sclerosis	1.02e-05	0.000876	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.01e-05	0.000871	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPC5—multiple sclerosis	1.01e-05	0.00087	CbGpPWpGaD
Diflunisal—TTR—Disease—CD4—multiple sclerosis	1.01e-05	0.000863	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RPL5—multiple sclerosis	9.73e-06	0.000835	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.58e-06	0.000822	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.55e-06	0.00082	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.37e-06	0.000804	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.34e-06	0.000801	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC11A1—multiple sclerosis	9.32e-06	0.000799	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CD80—multiple sclerosis	9.23e-06	0.000792	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.92e-06	0.000766	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	8.82e-06	0.000757	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—POMC—multiple sclerosis	8.77e-06	0.000752	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.72e-06	0.000748	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCL2—multiple sclerosis	8.58e-06	0.000736	CbGpPWpGaD
Diflunisal—ALB—Metabolism—RRM1—multiple sclerosis	8.4e-06	0.000721	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.05e-06	0.000691	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.95e-06	0.000682	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TYK2—multiple sclerosis	7.79e-06	0.000669	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—multiple sclerosis	7.79e-06	0.000668	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2RA—multiple sclerosis	7.75e-06	0.000665	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—BCHE—multiple sclerosis	7.51e-06	0.000644	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD28—multiple sclerosis	7.44e-06	0.000638	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—multiple sclerosis	7.24e-06	0.000621	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—multiple sclerosis	7.22e-06	0.00062	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK1—multiple sclerosis	7.08e-06	0.000608	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.92e-06	0.000594	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	6.88e-06	0.00059	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	6.75e-06	0.000579	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.52e-06	0.000559	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—multiple sclerosis	6.48e-06	0.000556	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.31e-06	0.000541	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—multiple sclerosis	6.14e-06	0.000527	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—BCHE—multiple sclerosis	5.96e-06	0.000512	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.6e-06	0.00048	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—multiple sclerosis	5.46e-06	0.000468	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—multiple sclerosis	5.44e-06	0.000467	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD86—multiple sclerosis	5.31e-06	0.000455	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—multiple sclerosis	5.07e-06	0.000435	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—multiple sclerosis	5.06e-06	0.000434	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK1—multiple sclerosis	4.96e-06	0.000426	CbGpPWpGaD
Diflunisal—ALB—Metabolism—BCHE—multiple sclerosis	4.82e-06	0.000414	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CCR5—multiple sclerosis	4.71e-06	0.000404	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HLA-A—multiple sclerosis	4.59e-06	0.000394	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—multiple sclerosis	4.55e-06	0.00039	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APOE—multiple sclerosis	4.52e-06	0.000388	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APOE—multiple sclerosis	4.28e-06	0.000368	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—POMC—multiple sclerosis	3.88e-06	0.000333	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD80—multiple sclerosis	3.87e-06	0.000332	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—multiple sclerosis	3.81e-06	0.000327	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APOE—multiple sclerosis	3.59e-06	0.000308	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—multiple sclerosis	3.55e-06	0.000304	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—multiple sclerosis	3.54e-06	0.000304	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK1—multiple sclerosis	3.48e-06	0.000298	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TYK2—multiple sclerosis	3.27e-06	0.000281	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—POMC—multiple sclerosis	3.08e-06	0.000264	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD4—multiple sclerosis	2.96e-06	0.000254	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APOE—multiple sclerosis	2.9e-06	0.000249	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—multiple sclerosis	2.81e-06	0.000241	CbGpPWpGaD
Diflunisal—ALB—Metabolism—POMC—multiple sclerosis	2.49e-06	0.000214	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—multiple sclerosis	2.29e-06	0.000196	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—multiple sclerosis	2.13e-06	0.000183	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—multiple sclerosis	2.12e-06	0.000182	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK1—multiple sclerosis	2.08e-06	0.000179	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—multiple sclerosis	1.6e-06	0.000137	CbGpPWpGaD
